Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

NCT03721341 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Tumors

Interventions

RADIATION: Palliative Radiation
DRUG: Chemotherapy
DRUG: Immunotherapy
DRUG: Hormones
OTHER: Observation
RADIATION: Stereotactic Ablative Radiotherapy

Sponsor

David Palma

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]